"Biotechnology entrepreneur [and Dartmouth Engineering Professor] Tillman Gerngross and research physician Michael Sporn, emeritus professor of pharmacology and toxicology at the Geisel School of Medicine, have been named the winners of Dartmouth’s Entrepreneurs Forum’s Technology Innovation and Commercialization awards," reports NH Business Review.

... "'Our awards highlight individuals who, through their inventive and entrepreneurial talents, have made strong contributions to Dartmouth and society,' Eric Fossum, associate provost for entrepreneurship and technology transfer, said.

"During the event, he called Gerngross and Sporn examples of innovators who are dedicated to improving human health.

"'Honestly, it was an easy choice in selecting Tillman and Michael. I am amazed by their energy, productivity, and success, and I am proud to have them as colleagues at Dartmouth.'

"Gerngross has founded many companies in the medical field, most recently Adagio Therapeutics, which is beginning clinical trials of antibodies engineered to protect against SARS-CoV-2, the virus that causes Covid-19."